相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Celeste Leigh Pearce et al.
LANCET ONCOLOGY (2012)
Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment
K. Sfiridaki et al.
MEDIATORS OF INFLAMMATION (2011)
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
Kristy J. Gotink et al.
ANGIOGENESIS (2010)
Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
Claudio Campa et al.
MEDIATORS OF INFLAMMATION (2010)
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
Stefan Sleijfer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma
Guru Sonpavde et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
FDA approves sorafenib for patients with inoperable liver cancer
Richard Peek et al.
GASTROENTEROLOGY (2008)
Medical progress: Age-related macular degeneration
Rama D. Jager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Anti-vascular endothelial growth factor therapy for ocular neovascular disease
Christopher M. Andreoli et al.
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non-small-cell lung cancer
Pasi A. Jaenne et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: A randomized, controlled trial
Elena Pope et al.
PEDIATRICS (2007)
Food and drug administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma
Edwin P. Rock et al.
ONCOLOGIST (2007)
Target practice: Lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer
Maartje Los et al.
ONCOLOGIST (2007)
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Ted Shih et al.
CLINICAL THERAPEUTICS (2006)
Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment
Anita N. Haggstrom et al.
PEDIATRICS (2006)
Combining targeted agents: Blocking the epidermal growth factor and vascular endothelial growth factor pathways
Alan Sandler et al.
CLINICAL CANCER RESEARCH (2006)
Phase I trial of a monoclonal antibody specific for αvβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion
DG McNeel et al.
CLINICAL CANCER RESEARCH (2005)
FDA drug approval summary:: Erlotinib (Tarceva®) tablets
MH Cohen et al.
ONCOLOGIST (2005)
Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody
B Pytowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice
M Fernandez et al.
GASTROENTEROLOGY (2004)
Long-term prognostic significance of neoangiogenesis in breast carcinomas: Comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression
JP Dales et al.
HUMAN PATHOLOGY (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Vascular endothelial growth factor and angiogenesis
A Hoeben et al.
PHARMACOLOGICAL REVIEWS (2004)
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression
CG Colpaert et al.
BRITISH JOURNAL OF CANCER (2003)
Risk for subsequent development of breast cancer
R Vang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
FDA drug approval summary: Gefitinib (ZD1839) (Iressa (R)) tablets
MH Cohen et al.
ONCOLOGIST (2003)
Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs
M Onimaru et al.
CIRCULATION RESEARCH (2002)
Growth factors for therapeutic angiogenesis in cardiovascular diseases
PR Vale et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2001)
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
MS Pepper
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Clinical trials in coronary angiogenesis: Issues, problems, consensus - An expert panel summary
M Simons et al.
CIRCULATION (2000)
分享论文
